Micronase and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Micronase (glyburide), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Glucophage, and have Type 2 diabetes.

The study is created by eHealthMe based on reports of 1,913 people who have side effects when taking Micronase from the FDA, and is updated regularly.

What is Micronase?

Micronase has active ingredients of glyburide. eHealthMe is studying from 1,922 Micronase users. Check the latest studies of Micronase.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

1,913 people reported to have side effects when taking Micronase.
Among them, 37 people (1.93%) died.

Among these 37 people:

How long have people been on Micronase when they died? *

What is the gender of people who died when taking Micronase? *

female: 34.62 %
male: 65.38 %

What is the age of people who died when taking Micronase? *

What are other drugs people take besides Micronase? *

What are other side effects people have before they died? *

Cardiac Failure Congestive: 10 people, 27.03%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 10 people, 27.03%
Acute Kidney Failure: 9 people, 24.32%
Bladder Cancer: 9 people, 24.32%
Urinary Tract Infection: 7 people, 18.92%
Chest Pain: 7 people, 18.92%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 7 people, 18.92%
High Blood Pressure: 7 people, 18.92%
Fainting (loss of consciousness and postural tone): 6 people, 16.22%
Hypoglycemia (low blood sugar): 6 people, 16.22%

What are the existing conditions these people have? *

Type 2 Diabetes: 11 people, 29.73%
Diabetes: 4 people, 10.81%
Joint Pain: 2 people, 5.41%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 5.41%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
Plantar Fasciitis (painful inflammatory process of the plantar fascia): 1 person, 2.70%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 2.70%
Dementia (madness): 1 person, 2.70%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 2.70%
Bone Loss: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micronase:

Micronase (1,922 reports)

Expand to all the drugs that have ingredients of glyburide:

Death and drugs with ingredients of glyburide (1,107 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,108 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Micronase) and Micronase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.